Evidence map›Paper›PMID 32928112›Full record

ArticleBMC microbiology2020

Development and clinical application of a novel CRISPR-Cas12a based assay for the detection of African swine fever virus.

Xiaoying Wang, Sheng He, Na Zhao, Xiaohong Liu, Yongchang Cao, Guihong Zhang, Gang Wang, Chunhe Guo

Abstract read
In one paragraph

Article in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. CRISPR-Cas12 Application for the Detection ofInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoying WangState Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, North Third Road, Guangzhou Higher Education Mega Center, Guangzhou, Guangdong, 510006, PR China.
Sheng HeState Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, North Third Road, Guangzhou Higher Education Mega Center, Guangzhou, Guangdong, 510006, PR China.
Na ZhaoPrecise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou, Guangdong, 510006, PR China.
Xiaohong LiuState Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, North Third Road, Guangzhou Higher Education Mega Center, Guangzhou, Guangdong, 510006, PR China.
Yongchang CaoState Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, North Third Road, Guangzhou Higher Education Mega Center, Guangzhou, Guangdong, 510006, PR China.
Guihong ZhangCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, Guangdong, 510642, PR China.
Gang WangPrecise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou, Guangdong, 510006, PR China. wanggang.v@gzhu.edu.cn.
Chunhe GuoState Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, North Third Road, Guangzhou Higher Education Mega Center, Guangzhou, Guangdong, 510006, PR China. guochunh@mail.sysu.edu.cn.ORCID 0000-0002-7859-1985

Funding

Developing methods for the detection of ASFV from the Guangdong Provincial Department of Science and Technology 2019B020211005 and 2019B020211003Science and Technology Planning Project for Guangzhou 201804020039
6 · The paper itself

Abstract

backgroundAs no treatment or effective vaccine for African swine fever virus (ASFV) is currently available, a rapid, highly sensitive diagnostic is urgently needed to curb the spread of ASFV.

resultsHere we designed a novel CRISPR-Cas12a based assay for ASFV detection. To detect different ASFV genotypes, 19 crRNAs were designed to target the conserved p72 gene in ASFV, and several crRNAs with high activity were identified that could be used as alternatives in the event of new ASFV variants. The results showed that the sensitivity of the CRISPR-Cas12a based assay is about ten times higher than either the commercial quantitative PCR (qPCR) kit or the OIE-recommended qPCR. CRISPR-Cas12a based assay could also detect ASFV specifically without cross-reactivity with other important viruses in pigs and various virus genotypes. We also found that longer incubation times increased the detection limits, which could be applied to improve assay outcomes in the detection of weakly positive samples and new ASFV variants. In addition, both the CRISPR-Cas12a based assay and commercial qPCR showed very good consistency.

conclusionsIn summary, the CRISPR-Cas12a based assay offers a feasible approach and a new diagnostic technique for the diagnosis of ASFV, particularly in resource-poor settings.

Indexed as

African Swine FeverAfrican Swine Fever VirusAnimalsBacterial ProteinsBloodCRISPR-Associated ProteinsCRISPR-Cas SystemsEndodeoxyribonucleasesMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesReal-Time Polymerase Chain ReactionRNA, ViralSensitivity and SpecificitySwineBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsEndodeoxyribonucleasesRNA, ViralAfrican swine fever; CRISPR-Cas12a; nucleic acid detection; diagnosis; qPCR

Identifiers

PMID32928112
PMCPMC7491166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.